DPA‐Zinc around Polyplexes Acts Like PEG to Reduce Protein Binding while Targeting Cancer Cells
Xuan Nie,Wei You,Ze Zhang,Fan Gao,Xiao‐Hong Zhou,Hai‐Li Wang,Long‐Hai Wang,Guang Chen,Chang‐Hui Wang,Chun‐Yan Hong,Qi Shao,Fei Wang,Lei Xia,Yang Li,Ye‐Zi You
DOI: https://doi.org/10.1002/adhm.202203252
IF: 10
2023-05-10
Advanced Healthcare Materials
Abstract:Gene therapy holds great promise as an effective treatment for many diseases of genetic origin. Gene therapy works by employing cationic polymers, liposomes, and nanoparticles to condense DNA into polyplexes via electronic interactions.Then, a therapeutic gene is introduced into target cells, thereby restoring or changing cellular function. However, gene transfection efficiency remains low in vivo due to high protein binding, poor targeting ability, and substantial endosomal entrapment. Artificial sheaths containing PEG, anions, or zwitterions can be introduced onto the surface of gene carriers to prevent interaction with proteins; however, they reduce the cellular uptake efficacy, endosomal escape, targeting ability, thereby, lowering gene transfection. Here, we report that linking dipicolylamine‐zinc (DPA‐Zn) ions onto polyplex nanoparticles can produce a strong hydration water layer around the polyplex, mimicking the function of PEGylation to reduce protein binding while targeting cancer cells, augmenting cellular uptake and endosomal escape. The polyplexes with a strong hydration water layer on the surface could achieve high gene transfection even in a 50% serum environment. This strategy provides a new solution for preventing protein adsorption while improving cellular uptake and endosomal escape. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials